Global Large Molecule Drugs CDMO Supply, Demand and Key Producers, 2024-2030

Global Large Molecule Drugs CDMO Supply, Demand and Key Producers, 2024-2030

The global Large Molecule Drugs CDMO market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Large Molecule Drugs CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Large Molecule Drugs CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Large Molecule Drugs CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Large Molecule Drugs CDMO total market, 2019-2030, (USD Million)

Global Large Molecule Drugs CDMO total market by region & country, CAGR, 2019-2030, (USD Million)

U.S. VS China: Large Molecule Drugs CDMO total market, key domestic companies and share, (USD Million)

Global Large Molecule Drugs CDMO revenue by player and market share 2019-2024, (USD Million)

Global Large Molecule Drugs CDMO total market by Type, CAGR, 2019-2030, (USD Million)

Global Large Molecule Drugs CDMO total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Large Molecule Drugs CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Patheon, Eurofins Scientific, Samsung Biologics, Catalent, Inc., Rentschler Biopharma SE, AGC Biologics, Recipharm AB, Siegfried Holding AG and FUJIFILM Diosynth Biotechnologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Large Molecule Drugs CDMO market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Large Molecule Drugs CDMO Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Large Molecule Drugs CDMO Market, Segmentation by Type
Cell Line Development
Large Molecule Drug Substance Development

Global Large Molecule Drugs CDMO Market, Segmentation by Application
Biological Technology
Clinical
Pharmaceutical
Others

Companies Profiled:
Patheon
Eurofins Scientific
Samsung Biologics
Catalent, Inc.
Rentschler Biopharma SE
AGC Biologics
Recipharm AB
Siegfried Holding AG
FUJIFILM Diosynth Biotechnologies
Scorpius
Ardena
Alcami
Cytiva
Thermo Fisher Scientific

Key Questions Answered

1. How big is the global Large Molecule Drugs CDMO market?

2. What is the demand of the global Large Molecule Drugs CDMO market?

3. What is the year over year growth of the global Large Molecule Drugs CDMO market?

4. What is the total value of the global Large Molecule Drugs CDMO market?

5. Who are the major players in the global Large Molecule Drugs CDMO market?